Myelodysplastic Syndrome (MDS) Drugs Market Outlook: 6.2% CAGR...

Ajouter une nouvelle offre d'emploi Health

2026-05-07 09:13:14

Myelodysplastic Syndrome (MDS) Drugs Market Outlook: 6.2% CAGR Growth Through 2031

According to a newly published market research report by 24LifeSciences, global myelodysplastic syndrome (MDS) drugs market was valued at USD 1,524 million in 2024 and is projected to reach USD 2,295 million by 2031, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period 20252031. Myelodysplastic syndromes represent a group of hematopoietic stem cell disorders...

0 Commentaires 0 Parts 47 Vue 0 Aperçu